MULTIPLAN CORP (MPLN)
US62548M1009 - Common Stock
MPLN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 37 industry peers in the Health Care Technology industry. While MPLN is still in line with the averages on profitability rating, there are concerns on its financial health. MPLN is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
MPLN had negative earnings in the past year.
In the past year MPLN had a positive cash flow from operations.
In multiple years MPLN reported negative net income over the last 5 years.
Each year in the past 5 years MPLN had a positive operating cash flow.
1.2 Ratios
Looking at the Return On Assets, with a value of -28.94%, MPLN is in line with its industry, outperforming 47.22% of the companies in the same industry.
Looking at the Return On Equity, with a value of -741.59%, MPLN is doing worse than 86.11% of the companies in the same industry.
With an excellent Return On Invested Capital value of 1.95%, MPLN belongs to the best of the industry, outperforming 80.56% of the companies in the same industry.
MPLN had an Average Return On Invested Capital over the past 3 years of 3.20%. This is below the industry average of 6.38%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -28.94% | ||
| ROE | -741.59% | ||
| ROIC | 1.95% |
ROA(3y)-2.62%
ROA(5y)-2.8%
ROE(3y)-11%
ROE(5y)-10.57%
ROIC(3y)3.2%
ROIC(5y)N/A
1.3 Margins
MPLN has a Operating Margin of 13.43%. This is amongst the best in the industry. MPLN outperforms 94.44% of its industry peers.
MPLN has a Gross Margin of 74.23%. This is amongst the best in the industry. MPLN outperforms 80.56% of its industry peers.
MPLN's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.43% | ||
| PM (TTM) | N/A | ||
| GM | 74.23% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.58%
GM growth 5YN/A
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MPLN is destroying value.
MPLN has less shares outstanding than it did 1 year ago.
MPLN has a worse debt/assets ratio than last year.
2.2 Solvency
MPLN has an Altman-Z score of -0.26. This is a bad value and indicates that MPLN is not financially healthy and even has some risk of bankruptcy.
With a Altman-Z score value of -0.26, MPLN perfoms like the industry average, outperforming 41.67% of the companies in the same industry.
MPLN has a debt to FCF ratio of 91.00. This is a negative value and a sign of low solvency as MPLN would need 91.00 years to pay back of all of its debts.
MPLN has a Debt to FCF ratio of 91.00. This is comparable to the rest of the industry: MPLN outperforms 52.78% of its industry peers.
MPLN has a Debt/Equity ratio of 21.73. This is a high value indicating a heavy dependency on external financing.
MPLN has a worse Debt to Equity ratio (21.73) than 86.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 21.73 | ||
| Debt/FCF | 91 | ||
| Altman-Z | -0.26 |
ROIC/WACC0.34
WACC5.71%
2.3 Liquidity
A Current Ratio of 1.05 indicates that MPLN should not have too much problems paying its short term obligations.
With a Current ratio value of 1.05, MPLN is not doing good in the industry: 61.11% of the companies in the same industry are doing better.
MPLN has a Quick Ratio of 1.05. This is a normal value and indicates that MPLN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MPLN (1.05) is worse than 61.11% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 |
3. Growth
3.1 Past
MPLN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -40.74%.
Looking at the last year, MPLN shows a decrease in Revenue. The Revenue has decreased by -1.66% in the last year.
Measured over the past years, MPLN shows a small growth in Revenue. The Revenue has been growing by 0.84% on average per year.
EPS 1Y (TTM)-40.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1415.62%
Revenue 1Y (TTM)-1.66%
Revenue growth 3Y0.84%
Revenue growth 5YN/A
Sales Q2Q%-5.07%
3.2 Future
Based on estimates for the next years, MPLN will show a very negative growth in Earnings Per Share. The EPS will decrease by -14.85% on average per year.
Based on estimates for the next years, MPLN will show a small growth in Revenue. The Revenue will grow by 0.46% on average per year.
EPS Next Y-1525.88%
EPS Next 2Y-21.51%
EPS Next 3Y-14.85%
EPS Next 5YN/A
Revenue Next Year-3.28%
Revenue Next 2Y-1.08%
Revenue Next 3Y0.46%
Revenue Next 5YN/A
3.3 Evolution
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for MPLN. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for MPLN. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, MPLN is valued cheaper than 94.44% of the companies in the same industry.
100.00% of the companies in the same industry are more expensive than MPLN, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 1.96 | ||
| EV/EBITDA | 8.17 |
4.3 Compensation for Growth
MPLN's earnings are expected to decrease with -14.85% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-21.51%
EPS Next 3Y-14.85%
5. Dividend
5.1 Amount
MPLN does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
MULTIPLAN CORP
NYSE:MPLN (12/20/2024, 8:25:24 PM)
After market: 6.32 +0.3 (+4.98%)6.02
-0.65 (-9.75%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)
Earnings (Next)
Inst Owners112.57%
Inst Owner Change-96.33%
Ins Owners254.13%
Ins Owner Change18.41%
Market Cap97.34M
Analysts77.78
Price Target11.22 (86.38%)
Short Float %4.23%
Short Ratio5.35
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-770.47%
Min EPS beat(2)-1467.36%
Max EPS beat(2)-73.58%
EPS beat(4)2
Avg EPS beat(4)-371.46%
Min EPS beat(4)-1467.36%
Max EPS beat(4)45.02%
EPS beat(8)4
Avg EPS beat(8)-430%
EPS beat(12)5
Avg EPS beat(12)-285.56%
EPS beat(16)9
Avg EPS beat(16)-170.55%
Revenue beat(2)0
Avg Revenue beat(2)-5.08%
Min Revenue beat(2)-6.88%
Max Revenue beat(2)-3.29%
Revenue beat(4)0
Avg Revenue beat(4)-4.78%
Min Revenue beat(4)-6.88%
Max Revenue beat(4)-3.13%
Revenue beat(8)2
Avg Revenue beat(8)-2.45%
Revenue beat(12)4
Avg Revenue beat(12)-2.76%
Revenue beat(16)7
Avg Revenue beat(16)15.62%
PT rev (1m)-63.33%
PT rev (3m)1258.02%
EPS NQ rev (1m)27.33%
EPS NQ rev (3m)-31042.9%
EPS NY rev (1m)31.69%
EPS NY rev (3m)-3482.02%
Revenue NQ rev (1m)-0.5%
Revenue NQ rev (3m)-13.62%
Revenue NY rev (1m)-0.29%
Revenue NY rev (3m)-0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.1 | ||
| P/FCF | 1.96 | ||
| P/OCF | 0.58 | ||
| P/B | 0.47 | ||
| P/tB | N/A | ||
| EV/EBITDA | 8.17 |
EPS(TTM)-63.05
EYN/A
EPS(NY)-8.86
Fwd EYN/A
FCF(TTM)3.07
FCFY51.06%
OCF(TTM)10.44
OCFY173.35%
SpS58.29
BVpS12.84
TBVpS-282.15
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -28.94% | ||
| ROE | -741.59% | ||
| ROCE | 2.47% | ||
| ROIC | 1.95% | ||
| ROICexc | 1.99% | ||
| ROICexgc | 38.28% | ||
| OM | 13.43% | ||
| PM (TTM) | N/A | ||
| GM | 74.23% | ||
| FCFM | 5.27% |
ROA(3y)-2.62%
ROA(5y)-2.8%
ROE(3y)-11%
ROE(5y)-10.57%
ROIC(3y)3.2%
ROIC(5y)N/A
ROICexc(3y)3.3%
ROICexc(5y)N/A
ROICexgc(3y)101.26%
ROICexgc(5y)N/A
ROCE(3y)4.05%
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y4.58%
GM growth 5YN/A
F-Score3
Asset Turnover0.18
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 21.73 | ||
| Debt/FCF | 91 | ||
| Debt/EBITDA | 8.11 | ||
| Cap/Depr | 27.69% | ||
| Cap/Sales | 12.63% | ||
| Interest Coverage | 0.4 | ||
| Cash Conversion | 30.33% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.05 | ||
| Altman-Z | -0.26 |
F-Score3
WACC5.71%
ROIC/WACC0.34
Cap/Depr(3y)22.91%
Cap/Depr(5y)20.73%
Cap/Sales(3y)9.07%
Cap/Sales(5y)8.3%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-40.74%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1415.62%
EPS Next Y-1525.88%
EPS Next 2Y-21.51%
EPS Next 3Y-14.85%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.66%
Revenue growth 3Y0.84%
Revenue growth 5YN/A
Sales Q2Q%-5.07%
Revenue Next Year-3.28%
Revenue Next 2Y-1.08%
Revenue Next 3Y0.46%
Revenue Next 5YN/A
EBIT growth 1Y-30.08%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year250.22%
EBIT Next 3Y54.41%
EBIT Next 5YN/A
FCF growth 1Y-82.64%
FCF growth 3Y-41.03%
FCF growth 5YN/A
OCF growth 1Y-55.36%
OCF growth 3Y-23.09%
OCF growth 5YN/A